BioSig Tech. (BSGM) & Electrophysiology Sector - Again the sicker NIAID Grade 3 patients - BioSig Tech. (BSGM) & Electrophysiology Sector - InvestorVillage
BioSig Tech. (BSGM) & Electrophysiology Sector (related stock BSGM)
  • TECH UPDATE: Please accept our apologies for the delay in getting our "board visit & message view" counts to normalize. As you may have noticed, starting yesterday the "board stats" for individual message boards started to display clearly erroneous "member" and "guest" visit counts. Needless to say, we don't like having unreliable traffic stats on the site any more than you do. Please understand this was not by design or intention. It's a glitch that resulted from an apparent incompatibility with the legacy code and the recent deployment of new servers to tackle issues related to last month's outage. In order to give our web developer a chance to take a closer look at the glitch and come up with a viable solution, we have decided to leave the code up for now so she can have real-world data to work with (rather than just turn the counts off again). So it looks like we may have to live with these bad counts a little longer, but our expectation is to have this resolved by early next week, if not sooner. We appreciate your patience and understanding.  
This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group

Group: BioSig Tech. (BSGM) & Electrophysiology Sector   /  Message Board  /  Read Message


Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1812 of 1871  at  9/25/2020 8:58:54 AM  by


The following message was updated on 9/25/2020 9:00:25 AM.

 In response to msg 1807 by  Rob Cos
view thread

Re: Again the sicker NIAID Grade 3 patients


Are you and other ViralClear direct stockholders suggesting to Londoner-Zeldis that a CEO letter or blog on the website be orchestrated soon regarding the expanded trial?

More clarity on the trial and expectations to include better timeframes for the signal to pivot to PIII etc. would change perceptions of this program.

Also, agree more progress on the roll-out of Pure EP...

Appreciate what you and others can do to voice investors concerns...

As an aside, Martha Pease recent Form 4 for 20,000 shares BSGM.

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 626
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Msg # Subject Author Recs Date Posted
1813 Re: Again the sicker NIAID Grade 3 patients Tucker10 1 9/25/2020 10:31:43 AM
1816 Re: Again the sicker NIAID Grade 3 patients Rob Cos 18 9/25/2020 12:41:23 PM

Financial Market Data provided by